Sambandet mellan säkerhetskrav och höga lagernivåer inom läkemedelsbranschen : En fallstudie på Fresenius Kabi

Sammanfattning: Background: An organization's ability to control bound material can be the difference between success or failure. Organizations that effectively work with supply chain management has strengthened their positions and increase their competitive edge on the global market. Organizations is the pharmaceutical industry has a major social responsibility by ensuring a continuous flow of medicines as well as pharmaceutical equipment. The industry is controlled by the strict regulations. The stringent security requirements for delivery reliability and delivery precision combined with extensive production regulations have resulted in these organizations having difficulty in maintaining even inventory levels.   Purpose: The study aims to investigating the correlation between high level of safety requirements in the pharmaceutical industry and high inventory levels with the help of a case study. The study wants to investigate consequences of such connection as well investigate potential solution in which organizations can reduce their inventory levels without jeopardizing the delivery precision and delivery safety of pharmaceutical organizations.   A case study has been conducted at the pharmaceutical company Fresenius Kabi who is a global market leader in the production of intravenous nutritional solutions.   Finding: Findings of the study indicates that safety requirements controlling the pharmaceutical industry have a major impact on the organization's production planning and storage. The consequences of the high security requirements results in in uneven production patterns and tied capital in high inventory levels. The consequences also indicated on a Bullwhip-effect. Lean management enables organizations in the pharmaceutical industry to establish even production patterns and reduce their inventory levels.   The study presents a new factor that prevents organizations in the pharmaceutical industry to reduce the number of articles. The new factor has a strong link to why organizations in the pharmaceutical industry have high inventory levels.